How the Medicare CBD Program Works

Name: How the Medicare CBD Program Works | Edify
Creator: Edify Wellness Team
Published: 2026-04-11

Written by the Edify Wellness Team

The Medicare CBD program operates through a federal benefit structure called the Substance Access Beneficiary Engagement Incentive, known as the BEI. It lets participating Accountable Care Organizations (ACOs) provide up to $500 per year in qualifying CBD products to eligible Medicare patients. The patient pays nothing. The ACO absorbs the cost.

This page explains the mechanics step by step. For the full picture including eligibility and product requirements, start with our complete Medicare CBD guide.

How It Works at a Glance

ACOs opt in voluntarily through CMS Innovation Center models
Doctors complete a documented shared decision-making visit with eligible patients
Qualifying products are furnished directly through the ACO
Medicare does NOT reimburse retail purchases
74 ACO REACH organizations participate across all 50 states

The Program Structure

The BEI exists within CMS's value-based care innovation program. Value-based care is a model where ACOs take on financial accountability for the health of their patient populations. When patients stay healthier, the ACO performs better financially. That structure creates an incentive to offer supplements like CBD that may help manage chronic conditions.

Two models currently support the BEI:

ACO REACH Model, a broad value-based care arrangement covering a wide range of patients
Enhancing Oncology Model, specifically focused on cancer patients and supportive oncology care

A third model, the LEAD Model, is expected to join the program. As the BEI expands into new CMS models, more patients will gain access.

The Step-by-Step Process

Here's how the benefit actually flows from your doctor's office to your hands:

Step 1: Your ACO Opts In

Participation in the BEI isn't automatic. Each ACO decides whether to offer the benefit as part of their care model. ACOs that choose to participate must follow CMS product standards and documentation requirements. Of the 74 ACO REACH organizations active across all 50 states, many have opted into the supplemental benefit framework.

Step 2: Your Doctor Opens the Conversation

Your physician or specialist reviews your health history and determines whether CBD is an appropriate option. They'll consider your current medications, your specific conditions, and whether you have any disqualifying factors (like substance use disorder or COPD).

Step 3: The Shared Decision-Making Visit

This is a critical step. CMS requires a documented consultation that covers five specific areas:

The potential benefits of CBD for your condition
Known risks and what the current evidence shows
Your personal goals and what you hope to get out of it
A full medication review to catch any potential interactions
A follow-up monitoring plan

This visit protects you and creates a clinical record. It's not a formality. It's designed to make sure CBD is integrated thoughtfully into your care.

Step 4: Products Are Furnished Through the ACO

Once the shared decision-making visit is complete, the ACO can provide qualifying CBD products to you. The products aren't mailed to you by a random retailer. They come through the ACO's supply chain, using products that meet CMS compliance standards.

Step 5: The ACO Absorbs the Cost

There's no billing code for CBD under Medicare Part D. You don't file a claim. You don't get reimbursed. The ACO covers the cost directly, up to $500 per patient per year.

Step 6: Your Doctor Monitors Your Response

The follow-up plan from Step 3 becomes active here. Your doctor tracks how you're responding to the CBD and adjusts your care plan accordingly. This ongoing documentation is part of what makes the BEI different from buying CBD at a store.

What Medicare Does Not Cover

It's worth being clear about what the program won't do:

Medicare will NOT reimburse you for CBD you bought at a pharmacy, grocery store, or online retailer
Medicare Part D does NOT include CBD as a covered drug
Medicare Advantage plans vary widely. Some may offer supplemental CBD benefits, but that's separate from the BEI

The key distinction is this: the benefit only works when your doctor, through a participating ACO, furnishes the product to you as part of your documented care plan. Retail purchases don't count.

One Supplier Doesn't Lock Out Others

You may have heard that one company (Cornbread Hemp) secured an exclusive GPO contract with a large purchasing organization called Alliant. That contract covers 68,000 provider locations. It sounds significant, and it is from a market share perspective. But ACOs are not required to use Alliant's contract. Any product that meets CMS compliance standards can be furnished through the program.

This matters for patients because it means you may be able to ask your ACO about specific products. Compliance requirements are the deciding factor, not exclusive vendor relationships.

The FDA's Role in This Program

The FDA issued an enforcement discretion memo stating it won't enforce certain restrictions on oral CBD products that are used within the BEI framework. This was a necessary step because hemp-derived CBD occupies a complex regulatory space. The memo cleared a path for ACOs to furnish products without FDA enforcement risk, as long as the products meet the CMS compliance criteria.

This isn't a permanent carte blanche. The FDA's position may evolve as federal hemp law changes. CMS has stated it will adjust program rules accordingly.

Edify Products and Program Compliance

Edify products are designed to meet the kind of rigorous compliance standards the BEI requires. Our hemp is grown on our Kentucky family farm through a Seed-to-Self process. Every batch is tested by independent third-party labs, and all results are published on our lab results page.

For patients purchasing directly rather than through an ACO, our Soothe Recovery CBD Gummies and Relieve CBD & CBG Tincture Full Spectrum are two popular options that align with the product profile the BEI targets.

We use nano-enhanced formulations to improve bioavailability, which means more of the CBD in each dose actually reaches your system. Our products are plant-based, vegan, and free of synthetic fillers.

Your cart is currently empty.